XASX
AHC
Market cap62mUSD
Oct 09, Last price
0.24AUD
1D
-2.08%
1Q
-4.08%
Jan 2017
177.09%
IPO
-25.40%
Name
Austco Healthcare Ltd
Chart & performance
P/E
9.78
P/S
0.93
EPS
0.02
Div yield, %
—
Shrs. gr., 5y
5.79%
Rev. gr., 5y
24.70%
Revenues
94m
+15.77%
Net income
9m
+51.80%
CFO
13m
-6.76%
Dividend
Mar 02, 20230.0017461 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Austco Healthcare Limited, through its subsidiaries, operates as a global entity focused on the development, production, and comprehensive servicing of advanced healthcare and electronic communication systems. The company's market reach extends across Australia, New Zealand, Asia, Europe, and North America. A significant product in its portfolio is Tacera, an internet protocol (IP) based nurse call solution specifically engineered for both hospitals and aged care facilities. Originally founded in 1986, the company adopted its current name, Austco Healthcare Limited, in November 2020, having previously been known as Azure Healthcare Limited. Its corporate headquarters are located in Port Melbourne, Australia.
Key people
Non-Executive Independent Chairman of the Board · since 2015
Peter DiBari
General Manager - Australia · since 2020
Peter Kamarinos
National Manager (Australia) · since 2012
Brendan J. Maher
Chief Financial Officer, Company Secretary · since 2018
Clayton Astles
Chief Executive Officer, Director · since 2015
Brett Burns
Non-Executive Independent Director · since 2015
Non-Executive Independent Director · since 2018
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||